Ketamine Therapy for Postpartum Depression: Fast Relief for Mothers

Exploring Esketamine (Spravato) and Ketamine Therapy for Treatment-Resistant Depression: Finding Relief for Parents

For adults navigating the demands of parenting, esketamine (Spravato) and off-label ketamine for depression may offer evidence-based pathways for relief when traditional depression treatments have not worked.

The Urgency of TRD Treatment and Parental Mental Health

Depression is complex; your brain isn't broken—it may be stuck. Following childbirth or during the early years of parenting, navigating major depressive disorder can feel deeply isolating. When the brain becomes trapped in rigid patterns of rumination and hopelessness, the Default Mode Network (DMN)—the brain system associated with self-reflection—can overvalue negative interpretations, leaving you feeling disconnected during a time when family connection is paramount.

Traditional oral antidepressants (SSRIs) can take four to six weeks to begin working^[7]—a timeline that feels agonizingly slow when every single day matters for infant bonding and parental well-being. This is why interventions like ketamine therapy are becoming an important option for adults with treatment-resistant depression.

How Glutamate and Neuroplasticity Shift the Brain

While traditional medications primarily target serotonin, norepinephrine, and dopamine, off-label ketamine—a racemic mixture containing both S-ketamine and R-ketamine molecules—acts fundamentally differently by targeting the brain's glutamate system.^[1] Glutamate is the primary excitatory neurotransmitter, and modulating it helps trigger a cascade that increases Brain-Derived Neurotrophic Factor (BDNF).^[2]

This biological mechanism helps create a path for rapid antidepressant action, allowing the brain to physically rebuild and interrupt the intense sense of futility that often accompanies severe depression.

"Ketamine induces the release of Brain-Derived Neurotrophic Factor, or BDNF, which acts as a growth hormone for the brain. Just as growth hormones in muscles cause hypertrophy and strength, BDNF enables brain cells to reach out and create new connections." – Dr. Ben Yudkoff, Chief Medical Officer, Lumin Health

Clinical Realities: Navigating Treatment as a Parent

One of the important conversations a mother will have with her clinical team involves breastfeeding. Because medications can pass into breast milk, a temporary pause in breastfeeding is typically required around the time of your ketamine treatment to help us deliver care safely. Our team reviews the long-term safety profile and pharmacokinetics to help you carefully plan this pause.

We work closely with you and your pediatrician to weigh these trade-offs. For many patients experiencing severe, treatment-resistant symptoms, prioritizing their immediate mental health recovery is an essential, loving decision they can make for their family.

What to Expect During Care

Based out of the Boston Metro area and expanding to other states, Lumin Health provides a specialized, psychiatrist-led environment for these treatments. We understand that stepping away from your family for a medical appointment is daunting. Our locations are designed to be calm, private, and deeply respectful of your time and emotional bandwidth.

• Timelines of relief: Many patients notice a softening of depressive symptoms within hours to days of their initial^[5] ketamine therapy sessions, breaking the futility loop.
• Supervised, comfortable administration: Whether receiving an intramuscular (IM) injection for off-label ketamine—an evidence-based, off-label application of a medicine that’s been in use for over 50 years—or navigating FDA-approved esketamine (Spravato), you receive psychiatric care and are monitored continuously by a dedicated team.
• Behavioral support: We encourage patients to use psychotherapy or their own self-guided practice in the days following a session to maximize the neuroplasticity window.

If you are navigating the heavy fog of depression and haven't found relief through traditional means, exploring ketamine for depression may be a fit. What matters most is what feels possible to you. As an organization rooted in Massachusetts and treating in other states, but serving as a resource for those seeking clarity nationwide, we invite you to evaluate your options. We would be grateful to walk with you toward relief. Check with your insurer or explore our treatment resources to learn more.

References

1. Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23(4):801-811. PubMed
2. Björkholm C, Monteggia LM. BDNF - a key transducer of antidepressant effects. Neuropharmacology. 2016;102:72-9. PubMed
3. Popova V, Daly EJ, Trivedi M, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. Am J Psychiatry. 2019;176(6):428-438. PubMed
4. Fu DJ, Ionescu DF, Li X, et al. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). J Clin Psychiatry. 2020;81(3). PubMed
5. Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351-4. PubMed
6. Short B, Fong J, Galvez V, et al. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018;5(1):65-78. PubMed
7. Taylor MJ, Freemantle N, Geddes JR, et al. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry. 2006;63(11):1217-23. PubMed

Take the first step today.

If you or a loved one in Massachusetts and the greater Washington DC/Maryland area is struggling with depression or anxiety, Lumin Health's team of experts is ready to help. Book a free 20-minute consultation to learn if ketamine therapy could be the breakthrough you've been looking for.

Available in Massachusetts and the greater Washington DC/Maryland area.

Book Your Free Consultation

Frequently Asked Questions

Can ketamine therapy help with postpartum depression?

It may. Esketamine (Spravato) is FDA-approved for adults with treatment-resistant depression and major depression with suicidal thoughts, and mothers whose depression meets those definitions may be candidates for this insurance-covered pathway. Off-label ketamine is another evidence-based option some parents consider when traditional antidepressants have not helped.

Can I keep taking my antidepressant during ketamine or Spravato treatment?

Yes. Most esketamine (Spravato) protocols are actually taken together with an oral antidepressant. Providers specifically trained in ketamine and esketamine review your full medication list to plan care safely.

Will I feel disconnected from my baby after a ketamine session?

The dissociative effects of treatment are expected, time-limited and closely monitored, typically resolving within an hour or two. Most parents find that once the medication clears, easing depressive symptoms actually supports feeling more present and bonded with their baby.